Bupivicaine
Bupivicaine is a pharmaceutical drug with 14 clinical trials. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
4
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
6 of 8 finished
25.0%
2 ended early
0
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Periarticular Injection Versus Popliteal Block
Stellate Ganglion Block (SGB) For Women for Breast Cancer
Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy
Transversus Abdominis Plane (TAP) Block for Post Caesarian Pain
Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery
Clinical Trials (14)
Periarticular Injection Versus Popliteal Block
Stellate Ganglion Block (SGB) For Women for Breast Cancer
Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy
Transversus Abdominis Plane (TAP) Block for Post Caesarian Pain
Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery
Implementation of a Pain Management Protocol for Total Knee Arthroplasty
Paravertebral Morphine Versus Dexmedetomidine on Acute and Chronic Postmastectomy Pain
Effectiveness of Continuous Femoral Nerve Block Versus Single Shot Femoral Nerve Block for Pain Control
Dexmedetomidine for Sedation in Total Knee Replacements
A Trial Comparing Adductor Canal Catheter and Intraarticular Catheter Following Primary Total Knee Arthroplasty
Greater Occipital Nerve Block for Migraine Prophylaxis
Pain Management Following TRAM Flap for Breast Reconstruction
A Pilot Study of Bupivacaine Infusion in Abdominal Surgery
Patient Controlled Epidural Analgesia Versus Continuous Epidural Infusion: Obstetrical and Neonatal Outcomes
All 14 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 14